C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance

Marina Cardellini, Lucia Perego, Monica D'Adamo, Maria Adelaide Marini, Cristina Procopio, Marta Letizia Hribal, Francesco Andreozzi, Simona Frontoni, Maurizio Giacomelli, Michele Paganelli, Antonio E. Pontiroli, Renato Lauro, Franco Folli, Giorgio Sesti

Research output: Contribution to journalArticlepeer-review

71 Scopus citations


OBJECTIVE - The C-174G promoter polymorphism of the interleukin (IL)-6 gene was found to influence transcnptional activity and plasma IL-6 levels in humans. We addressed the question of whether the C-174G IL-6 polymorphism contributes to variation of insulin sensitivity. RESEARCH DESIGN AND METHODS - Two cohorts of subjects were genotyped. Cohort 1 includes 275 nondiabetic subjects who underwent a euglycemic-hyperinsulinemic clamp. Cohort 2 includes 77 patients with morbid obesity who underwent laparoscopic adjustable gastric banding (LAGB). RESULTS - The genotypes were consistent with Hardy-Weinberg equilibrium proportions. In cohort 1, insulin sensitivity was reduced in carriers of the -174G/G genotype as compared with subjects carrying the C allele (P = 0.004). Carriers of -174G/G displayed significantly higher plasma IL-6 levels in comparison with carriers of the C allele. In a stepwise linear regression analysis, the C-174G polymorphism was independently associated with insulin sensitivity; however, after inclusion of plasma IL-6 concentrations, the polymorphism was excluded from the model explaining insulin sensitivity variability, thus suggesting that the polymorphism was affecting insulin sensitivity by regulating IL-6 plasma levels. IL-6 mRNA levels were measured by real-time RT-PCR in subcutaneous fat obtained from obese patients of cohort 2 during LAGB. Carriers of -174G/G showed increased IL-6 expression compared with subjects carrying the C allele (P = 0.04). There was a significant correlation between adipose IL-6 mRNA expression and insulin resistance assessed by homeostasis model assessment (p = 0.28, P = 0.014). CONCLUSIONS - These results indicate that the -174G/G genotype of the IL-6 gene may contribute to variations in insulin sensitivity.

Original languageEnglish (US)
Pages (from-to)2007-2012
Number of pages6
JournalDiabetes care
Issue number8
StatePublished - Aug 2005

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing


Dive into the research topics of 'C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance'. Together they form a unique fingerprint.

Cite this